Illumination BrandsIllumination BrandsIllumination BrandsIllumination Brands
  • Home
  • Contact Us
✕
Medical Cannabis and CBD Associated with Sustained Improvements in Chronic Pain Patients in Recent Study
  • Home
  • The Movement- News and Articles about the Industry
  • cannabis use
  • Medical Cannabis and CBD Associated with Sustained Improvements in Chronic Pain Patients in Recent Study
Medical Cannabis and CBD Associated with Sustained Improvements in Chronic Pain Patients in Recent Study

The long-term use of cannabis provides sustained improvements in patients suffering from chronic pain conditions, according to longitudinal data published in the journal Experimental and Clinical Psychopharmacology.

A team of investigators affiliated with Harvard Medical School and McLean Hospital in Boston evaluated the use of cannabis or CBD in chronic pain patients over a six-month period. Most participants in the study suffered from either musculoskeletal pain or neuropathy.

The researchers reported: “Relative to baseline, following 3 and 6 months of treatment, medical cannabis patients exhibited improvements in pain which were accompanied by improved sleep, mood, anxiety, and quality of life. … Reduced pain was associated with improvements in aspects of mood and anxiety.”

Authors also acknowledged that many subjects reduced their use of opioids over the trial period, though not to a degree that reached statistical significance. They concluded, “ these findings are promising, as they underscore previous survey studies also reporting the reduced use of conventional medications, specifically opioids, following the initiation of medical cannabis treatment.”

Additionally, researchers reported that patients with similar pain conditions who did not initiate medical cannabis therapy over the study period “did not reveal a similar pattern of improvement as the medical cannabis patients on measures of pain or clinical measures between baseline and follow-up.”

The authors also concluded: “Findings suggest that medical cannabis may be an effective adjunctive therapeutic strategy for chronic pain and related symptoms for at least a subset of patients. Future studies are needed to gather data which could ultimately help physicians make specific recommendations regarding MC treatment regimens optimized for pain relief.”

Patients in the United States seeking medical cannabis recommendations are most likely to report suffering from chronic pain, according to an analysis published in February in the Journal of Cannabis Research.

As the evidence continues to mount for the alleviation of chronic pain with the use of CBD or medical cannabis, the amount of scrutiny being directed at the CBD industry continues to increase, as it becomes a billion dollar industry worldwide.

Share
62

Related posts

Global Sciences
March 24, 2022

CBD Global Sciences, dba Global Sciences Inc. to Acquire Pure BioPlastics Inc., a Colorado Renewable Plastics Company


Read more
Global Sciences
March 15, 2022

CBD Global Sciences Begins the Process for a Name Change


Read more
Oowee Lemonade
February 16, 2022

CBD Global Sciences Legacy Distribution Experiences Better Than Expected Launch of Rap Snacks in the Colorado Market


Read more
Debt Restructuring
December 31, 2021

CBD Global Sciences Announces Retirement of Over $9 Million in Outstanding Debt


Read more

Contact Us

We are always here to answer your questions.

Contact Us

Privacy Policy

© 2024 Illumination Brands | All Rights Reserved | Design by Digital Warlock.